ACO Name and Location

PMC ACO LLC
Previous Names: N/A
2425 S Linden Road
Suite B
Flint, MI 48532

 

ACO Primary Contact

Primary Contact Name Mike Grodus
Primary Contact Phone Number 734-302-2108
Primary Contact Email Address mgrodus@medadvgrp.com

 

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Asif Ishaque, M.D., P.C. N
Badar Ahmed M.D., P.C. N
Michigan Internal Medicine & Pediatrics, P.C. N
SAGINAW VALLEY WALK IN CLINIC PLLC N
E Saeed MD PC N
Flushing Healthcare, PC N
Fenton Medical Center N
Abdullah Raffee, M.D., PC N
Dr. Jon L. Schriner, DO PC N
Genesee Family Care PC N
Hurley Health Services N
Physician Coverage Services, PC N
M.W. Eustace M.D. PLC N
Mary Marshall, MD, PC N
Ahmad Al-Dabagh MD PC N
A. Almansour, M.D., P.C. N
Caroline D Mathew, MD, PC N
F Khan Md Pc N
Ahmed A. Arif MD PC N
CASS RIVER HEALTH PLAZA PLLC N
Vibha N
MOHAMED ALLY HEALTH PLAZA PLLC N
CARO HEALTH PLAZA PLC N
Global Family Care PLC N
COLUMBIAVILLE FAMILY CLINIC PLLC N
ST CHARLES FAMILY CLINIC PLLC N
Josephine C. Bello, M.D., P.L.C N
AMANDA WINSTON MD PLLC N

 

 

ACO governing body:

Member Member’s Voting Power –Expressed as a percentage or number Membership Type – ACO Participant Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Ishaque Asif President Voting Member – 1 Vote ACO Participant Asif Ishaque, M.D., P.C.
Syed Mohammed Treasurer Voting Member – 1 Vote ACO Participant Ahmed A. Arif MD PC
Duncan Deborah Vice President Voting Member – 1 Vote ACO Participant Fenton Medical Center
Eustace Manoharan   Voting Member – 1 Vote ACO Participant M.W. Eustace M.D. PLC
Khan Farhan Medical Director Voting Member – 1 Vote ACO Participant F Khan Md Pc
Saeed Seif   Voting Member – 1 Vote ACO Participant Physician Coverage Services, PC
Saeed Elmahdi Secretary Voting Member – 1 Vote ACO Participant E Saeed MD PC
Hamilton Richard   Voting Member – 1 Vote Medicare Beneficiary Representative N/A
Jaggi Michael   Non-Voting Member – 0 Vote Community Stakeholder Representative N/A

 

Key ACO clinical and administrative leadership:

Asif Ishaque ACO Executive
Farhan Khan Medical Director
Ben Bawcum Compliance Officer
Farhan Khan Quality Assurance/Improvement Officer

 

 

 

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Medial Management Committee Asif Ishaque, M.D., Chair
Care Management Oversight Committee Farhan Khan, M.D., Chair
Compliance Committee Ben Bawcum, Chair
   

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2018, $0
    • Performance Year 2017, $0
  • First Agreement Period
    • Performance Year 2016, $4,292,165
    • Performance Year 2015, $4,176,382
    • Performance Year 2014, $0

 

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 5%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 95%
    • Performance Year 2015
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 80%
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

 

Quality Performance Results

2018 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 87.83 86.14
ACO-2 CAHPS: How Well Your Providers Communicate 92.81 93.93
ACO-3 CAHPS: Patients’ Rating of Provider 90.50 92.45
ACO-4 CAHPS: Access to Specialists 86.12 81.50
ACO-5 CAHPS: Health Promotion and Education 64.36 59.26
ACO-6 CAHPS: Shared Decision Making 57.61 61.94
ACO-7 CAHPS: Health Status/Functional Status 71.55 73.35
ACO-34 CAHPS: Stewardship of Patient Resources 33.45 26.26
ACO-8 Risk Standardized, All Condition Readmission 15.12 14.98
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 19.53 18.59
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 43.98 37.01
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 91.32 76.75
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 65.50 59.00
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) 2.25 1.98
ACO-11 Use of Certified EHR Technology 99.33 98.20
ACO-12 Medication Reconciliation Post-Discharge 99.47 85.91
ACO-13 Falls: Screening for Future Fall Risk 87.26 79.73
ACO-44 Use of Imaging Studies for Low Back Pain 77.14 64.36
ACO-14 Preventive Care and Screening: Influenza Immunization 71.74 72.71
ACO-15 Pneumonia Vaccination Status for Older Adults 79.80 75.97
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 83.60 76.83
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 68.18 72.81
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 75.89 66.74
ACO-19 Colorectal Cancer Screening 71.04 68.27
ACO-20 Breast Cancer Screening 78.52 71.96
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 79.94 81.47
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 18.05 15.51
ACO-41 Diabetes: Eye Exam 68.59 52.42
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 72.58 73.10
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet 85.66 88.92

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

 

Note: In the Quality Performance Results file(s) above, search for “PMC ACO LLC” or “PMC ACO” to view the quality performance results. This ACO can also be found by using the ACO ID A2246 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.
Copyright © 2017